赛诺医疗:中信证券股份有限公司关于赛诺医疗科学技术股份有限公司首次公开

来源:巨灵信息 2020-10-22 00:00:00
关注证券之星官方微博:
“ ” “ ”
    
    “ ” “ ” “ ”
    
    2019 9 27
    
    [2019]1794
    
    5,000 2019 10 30
    
    36,000
    
    41,000 364,829,987
    
    45,170,013
    
    12
    
    22 239,880,545 58.51%2020 10 30
    
    1 Great Noble Investment Limited Denlux MicroportInvest Inc. Denlux Capital Inc. Decheng Capital China Life Sciences USD Fund I,L. P. CSF Stent Limited LYFE Capital Blue Rocket (Hong Kong) Limited ChampStar Technology Limited
    
    ( )
    
    Javelin Capital International Limited
    
    12
    
    2 CAI HONG
    
    1 12
    
    2
    
    3 Great Noble Investment Limited Denlux Microport Invest Inc.Decheng Capital China Life Sciences USD Fund I, L. P. CSF Stent Limited LYFECapital Blue Rocket (Hong Kong) Limited
    
    1 /
    
    /
    
    2 /
    
    /
    
    5%
    
    / 15
    
    / 3
    
    3 / /
    
    4 / /
    
    /
    
    /
    
    4
    
    1 12
    
    2 / /
    
    25%
    
    3 / 6
    
    20 6
    
    6
    
    4
    
    5
    
    5
    
    1 12
    
    2
    
    25% 6
    
    3 / /
    
    25% 6
    
    18
    
    7 12
    
    12
    
    4 / 6
    
    20 6
    
    6
    
    5
    
    6
    
    6
    
    1 36
    
    2 6 20
    
    6
    
    6
    
    3
    
    4
    
    239,880,545
    
    2020 10 30
    
                                                       %
       1   GreatNobleInvestment       58,817,378       14.35        58,817,378      0
           Limited
       2   DenluxMicroportInvestInc.   29,740,572        7.25        29,740,572      0
       3   DechengCapitalChinaLife    24,607,545        6.00        24,607,545      0
           Sciences USDFundI,L.P.
       4   CSFStentLimited           24,478,395       5.97        24,478,395      0
       5   LYFECapitalBlueRocket     22,503,866        5.49        22,503,866      0
           (Hong Kong)Limited
       6   ChampStarTechnology       10,093,669        2.46        10,093,669      0
           Limited
       7                              9,642,854        2.35         9,642,854       0
       8   DenluxCapitalInc.           9,463,207        2.31         9,463,207       0
       9                              8,035,710        1.96         8,035,710       0
      10                              7,761,104        1.89         7,761,104       0
      11                              6,703,181        1.63         6,703,181       0
      12                              4,821,431        1.18         4,821,431       0
      13                              4,821,431        1.18         4,821,431       0
      14    JavelinCapitalInternational    3,388,945        0.83         3,388,945       0
           Limited
      15                              3,214,288        0.78         3,214,288       0
      16    CAIHONG                 3,150,415        0.77         3,150,415       0
      17                              2,205,263        0.54         2,205,263       0
      18                       (      1,607,144        0.39         1,607,144       0
                 )
      19                              1,607,144        0.39         1,607,144       0
      20                              1,525,570        0.37         1,525,570       0
      21                              1,223,758        0.30         1,223,758       0
      22                              467,675         0.11         467,675       0
                                     239,880,545      58.51       239,880,545      0
    
    
    1
    
    2
    
    12
    
    25%
    
    3
    
    12
    
    25%
    
    4
    
    12
    
    25%
    
    5
    
    12
    
    25% 6
    
    6
    
    12
    
    25% 6
    
    7
    
    12
    
    36
    
                                                       239,880,545
                                                       239,880,545

查看公告原文

微信
扫描二维码
关注
证券之星微信
相关股票:
好投资评级:
好价格评级:
证券之星估值分析提示赛诺医疗盈利能力一般,未来营收成长性较差。综合基本面各维度看,股价偏高。 更多>>
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。如该文标记为算法生成,算法公示请见 网信算备310104345710301240019号。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-